Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Teekay Offshore Shares Spike 30% Higher on Brookfield Merger Agreement

Teekay Offshore Partners shares are trading more than 30% higher today on news that Brookfield Business Partners will be purchasing all un-owned common units of the firm for $1.55 per share. This morning Hamilton, Bermuda based Teekay Offshore Partners L.P. (TOO:NYSE...

Pope Resources Shares Rise 35% on Rayonier $554 Million Takeover Bid

Pope Resources LP shares set a new 52-week intraday high price today after the timber resources firm announced that it agreed to be acquired by Rayonier for $554 million, or $126.91 per unit. The transaction is expected to close in mid-year 2020 subject to approval of Pope's u...

New Deal 'Step In Right Direction Toward Turnaround for Energy Firm'

The new agreement and its potential impact on Point Loma Resources are discussed in a Mackie Research Capital Corp. report. In an April 21 research note, Mackie Research Capital Corp. analyst Bill Newman wrote that the transaction outlined in Point Loma Res...

Dova Pharma Shares Rise 38% on Swedish Firm Takeover Offer

Shares of Dova Pharmaceuticals opened 38% higher today on news that the firm will be acquired by Swedish Orphan Biovitrum. The deal is reportedly valued at $915 million or $29/share. This morning Durham, N.C.-based Dova Pharmaceuticals Inc. (DOVA:NASDAQ) announced ...

Oil & Gas Company's 'Borrowing Base Confirmed,' 2019 Capital Program Fully Funded

This finance news was covered in a Mackie Research Capital Corp. report. In an April 10 research note, Mackie Research Capital Corp. analyst Bill Newman reported that Prairie Provident Resources Inc.'s (PPR:TSX) US$60 million, senior-secured revolving note facility wa...

Energy Infrastructure Firm Posts Solid Q1/19, Remains 'Poised to Outperform'

A recap of this Texas company's first quarter was provided in a Raymond James report. In an April 18, 2019 research note, Raymond James analyst Justin Jenkins reported that Kinder Morgan Inc. (KMI:NYSE) had a "mostly quiet," Q1/19, showing "strong performance on ...

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

An explanation of the categorization and its implications are provided in a Paradigm Capital report. In a May 30 research note, Paradigm Capital analyst Rahul Sarugaser reported that Zymeworks Inc.'s (ZYME:NYSE; ZYME:TSX) lead product candidate ZW25 wa...

Amgen Shares React Favorably to Enbrel Patent Case Victory

Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...

Mallinckrodt Shares Up 60% as It Announces Sale of Unit

Shares of Mallinckrodt Plc are trading more than 60% higher today on news that the company is selling its CDMO subsidiary BioVectra Inc. to H.I.G. Capital for $250 million. Global biopharmaceutical company Mallinckrodt Plc (MNK:NYSE) announced today that it has ent...

Fibrocell Science Shares Rise 60% on Acquisition News

Fibrocell Science's shares are trading up 60% today after the company announced that it agreed to be acquired by Castle Creek Holdings for $63.3 million, or $3.00 per share. Cell and gene therapy company Fibrocell Science Inc. (FCSC:NASDAQ) , which focuses on transfo...
1 2 3 4 5 6 7 8 9 10 ...